🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseDe novo lipogenesis reduction on GLP-1 — my results so far Page 3

De novo lipogenesis reduction on GLP-1 — my results so far

DadBodDave Sat, Aug 17, 2024 at 6:42 PM 14 replies 2,052 viewsPage 3 of 3
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
Aug 23, 2024 at 7:58 AM#11
DeniseRN_TPA said:
The version of this that has an answer is narrower than the version being asked.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

42 15NurseKim_ATL, paul_denver, TinaHashiRN and 39 others
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Aug 24, 2024 at 11:46 PM#12
SleepDoc_PDX said:
Liver enzyme update related to liver and MASH: I had mildly elevated ALT/AST at baseline (likely NAFLD).

Saving this. It is the first explanation that did not require me to already understand it.

Last edited: Aug 25, 2024 at 1:46 AM
43 16james_edin, FranDenver, Dr.BariatricHTX and 40 others
Reply Quote Save Share Report
wei_SG
Member
234
890
Nov 2024
Singapore, SG
Aug 26, 2024 at 3:33 PM#13
DeniseRN_TPA said:
The version of this that has an answer is narrower than the version being asked.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

Last edited: Aug 26, 2024 at 4:33 PM
44 17Dr.MetabolicMD, RetaRick_CA, JenPlateau and 41 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
DoseLogDan
Member
201
567
Feb 2025
Montana
Aug 28, 2024 at 7:19 AM#14

The figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Last edited: Aug 28, 2024 at 8:19 AM
45 18sophie_paris, mel_PDX, Dr.AddMedPHL and 42 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Aug 29, 2024 at 11:05 PM#15

Moderator note: a couple of off-topic posts removed. Thread quality here is what the rules are for. Keep it up.

Last edited: Aug 30, 2024 at 1:05 AM
46 19PurityPaulOR, MaxMetOK, MounjBrad and 43 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register